PCAP
GILD icon

Pratt Collard Advisory Partners’s Gilead Sciences GILD Stock Holding History

Pratt Collard Advisory Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,250
Closed -$203K – 112
2018
Q4 		$203K Hold
3,250
– – 0.18% 97
2018
Q3 		$251K Hold
3,250
– – 0.2% 93
2018
Q2 		$230K Sell
3,250
-200
-6% -$14.1K 0.2% 100
2018
Q1 		$260K Sell
3,450
-200
-5% -$15.9K 0.23% 98
2017
Q4 		$261K Buy
+3,650
New +$277K 0.21% 98

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Pratt Collard Advisory Partners's GILD Position: Q1 2019 in Review

Pratt Collard Advisory Partners sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 3,250 shares — an estimated $203K sold.

Pratt Collard Advisory Partners first reported a position in GILD in Q4 2017 and held it in 5 quarters. The position peaked at $261K in Q4 2017. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Pratt Collard Advisory Partners reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Pratt Collard Advisory Partners sold 3,250 Gilead Sciences shares in Q1 2019, an estimated $203K.
  • Pratt Collard Advisory Partners first reported a position in Gilead Sciences in Q4 2017 and held it in 5 quarters.
  • Pratt Collard Advisory Partners's Gilead Sciences position peaked at $261K in Q4 2017.
  • 1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Pratt Collard Advisory Partners's 13F filing for Q1 2019, filed 16 Apr 2019.